Martin Tami Tillotson Insider Trading Activity

Average Profitability
29.48%
Insider Buys Quantity
1
Insider Buys Sum
$12,500.00
Insider Sells Quantity
7
Insider Sells Sum
$1.26M

Insider Activity of Martin Tami Tillotson

Biography of Martin Tami Tillotson

No biography is available at this moment.

2024-01-10SaleSupernus Pharmaceuticals, Inc.
SUPN
Sr. V.P., Regulatory Affairs
8,000
0.0146%
$27.91$223,280+10.7%
2023-08-30SaleSupernus Pharmaceuticals, Inc.
SUPN
Sr. V.P., Regulatory Affairs
8,100
0.0149%
$32.00$259,200-11.32%
2023-08-25SaleSupernus Pharmaceuticals, Inc.
SUPN
Sr. V.P., Regulatory Affairs
5,135
0.0095%
$31.59$162,215-9.73%
2022-08-22SaleSupernus Pharmaceuticals, Inc.
SUPN
Sr. V.P., Regulatory Affairs
5,000
0.0095%
$35.98$179,900-0.91%
2022-08-04SaleSupernus Pharmaceuticals, Inc.
SUPN
Sr. V.P., Regulatory Affairs
5,000
0.0093%
$32.98$164,900+6.67%
2021-04-14SaleSupernus Pharmaceuticals, Inc.
SUPN
Sr. V.P., Regulatory Affairs
6,250
0.0083%
$22.48$140,500-5.62%
2021-04-13SaleSupernus Pharmaceuticals, Inc.
SUPN
Sr. V.P., Regulatory Affairs
6,250
0.0081%
$21.48$134,264-3.87%
2012-05-04PurchaseSupernus Pharmaceuticals, Inc.
SUPN
VP of Regulatory Affairs
2,500
0.0124%
$5.00$12,500+29.48%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.